Drugmaker ProEthic Pharmaceuticals says that its new fast-acting migraine medicine continues to show promise in clinical trials. The drug, currently known as PRO-513, relieved migraine patients' pain, nausea, and sensitivity to light or sound better than a placebo in the latest studies.
Read moreThe Migraine Research Foundation has added a great new resource for Migraine sufferers on our website - a new and improved list of doctors... Read more »
We frequently discuss that it's important for our doctors to know about any over-the-counter (OTC) medications we take for Migraines and... Read more »
Hello, everyone! Some weeks, we accumulate quite a bit of new Migraine and headache material on MyMigraineConnection. I realize some of... Read more »
Patients and health care professional alike diligently search for any treatments that are effective for Migraines. Researchers have been... Read more »
Emergency department visits for headache disorders, Migraine in particular, is the topic of a report issued this month by the Agency for... Read more »
Source: Medifocus Guidebook on: Migraine Headache
There are no studies to prove the efficacy or safety of most alternative therapies. It is important that migraineurs notify their health care... Read more »
A new migraine medicine called telcagepant was found safe and effective at treating migraines in a new comparative study with the migraine drug... Read more »
Phase II study data on MK-0974, an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist showed:MK-0974 significantly... Read more »
Tuesdays New York Times article Scientists Cast Misery of Migraine in a New Light highlights research that indicates that much of what we think... Read more »
Scientists say they may have found a new "target" for future migraine medicines. New research published in the medical journal The Lancet suggest... Read more »